Old West Investment Management, LLC Merus N.V. Transaction History

Old West Investment Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$10.57 - $16.0 $168,485 - $255,040	-15,940 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$10.5 - $17.36 $88,284 - $145,962	-8,408 Reduced 34.53%	15,940 $256,000
Q1 2020 May 15, 2020	SELL	$11.34 - $19.44 $27,567 - $47,258	-2,431 Reduced 9.08%	24,348 $294,000
Q4 2019 Feb 11, 2020	BUY	$14.08 - $18.5 $377,048 - $495,411	26,779 New	26,779 $377,000

203

61.9M

243K

300K

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $1.81B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

Get notified when there are updates to the investment portfolio of Old West Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Old West Investment Management, LLC with notifications on news.